ALZBrainTrust’s New Guide: Making Alzheimer’s Research Participation More Accessible

See what is blocking diverse Alzheimer's trial enrollment and practical steps to find a study near you.

ALZBrainTrust is an Alzheimer's Association initiative to make dementia research participation more equitable. Its new Community First Engagement Guide shares lessons from community-centered work to improve outreach. The guide focuses on Black/African American and Hispanic/Latino communities. It documents barriers, local engagement models, and practical steps to strengthen recruitment nationally.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Why trial enrollment stays unequal

An analysis of more than 100 Alzheimer's treatment trials found only 12% of participants were non-White or Hispanic. Black and Latino adults face higher dementia risk, according to analysis from USC Keck and the Alzheimer's Clinical Trial Consortium.

That gap matters for care decisions. When trials enroll narrow groups, results say less about higher-risk communities. Families then face treatment choices with less relevant evidence.

How three city hubs changed recruitment

ALZBrainTrust works through metropolitan hubs in Chicago, Houston and Los Angeles. Each hub unites local chapters, academic researchers and 13 community partners to co-design recruitment strategies, as described on the Alzheimer's Association ALZBrainTrust page. The initiative uses a community-based participatory research model.

That model centers community knowledge to identify systemic barriers facing Black/African American and Hispanic/Latino communities. In Los Angeles, the program partnered with the Beta Psi Lambda chapter of Alpha Phi Alpha fraternity. The partnership focused on trusted relationships that support research participation, according to the Association's Health Equity Impact Report.

What the guide adds for research teams

The guide records participation barriers for Black and Hispanic communities. It also describes the engagement model each hub developed. It then offers practice-based recommendations to strengthen national recruitment.

The recommendations reflect local experience, not a single national script. That local focus aligns with wider policy pressure. The U.S. Food and Drug Administration says sponsors of certain trials must submit Diversity Action Plans with enrollment goals and measures for underrepresented populations under FDORA.

How to look for a study now

Alzheimer's Association TrialMatch is a practical starting point for families. People with impairment, caregivers and healthy volunteers can answer online questions, receive matching studies and get email alerts about new trials, according to the Alzheimers.gov description of TrialMatch.

The guide offers practice recommendations, not guaranteed trial eligibility. Medical criteria and study-site access still determine enrollment.

  • Answer the online questions about health, caregiving role and location
  • Review the list of possibly matching studies
  • Sign up for email alerts about new trials
  • Contact the listed study team to discuss next steps

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.